1. Home
  2. News
  3. Dimerix Limited
  4. Successful Completion of DSMB Review of Phase 3 FSGS Trial
More Dimerix Limited news
Dimerix LimitedASX: DXB

Successful Completion of DSMB Review of Phase 3 FSGS Trial

Feb 8, 2023 at 10:24 PM EST · Issued by Dimerix Limited

Filed with ASX · Feb 8, 2023 at 10:24 PM EST · 4 pages · English

On 6ix: 6ix.com/news/successful-completion-of-dsmb-review-of-phase-3-fsgs-trial

Dimerix Limited on 6ix

Story so far

  • First Approvals Received for Start of Phase 3 FSGS TrialOct 21, 2021

Earlier from Dimerix

  • FDA Confirms Inclusion of Paediatrics in ACTION3 StudyJan 11, 2023
  • DMX-200 FSGS Phase 3 Trial Part 1 Recruitment AchievedDec 14, 2022
  • CLARITY 2.0 COVID-19 Study OutcomeDec 12, 2022
  • Chair address and CEO presentation to AGMNov 28, 2022
  • Dimerix Receives A$6.0M R&D Tax Incentive RebateOct 24, 2022

Later from Dimerix

  • DXB to Receive $2.8m in Prepayment of R&D Tax IncentiveFeb 16, 2023
  • Half-Year Financial Report & Appendix 4D - 31 December 2022Feb 26, 2023
  • Voluntary SuspensionMay 2, 2023
  • Entitlement offer and Convertible Note to raise $12 millionMay 3, 2023
  • Reinstatement to Official QuotationMay 3, 2023
All Dimerix news releases↗

Follow Dimerix into a list and get an email when it puts out news.

Follow Dimerix
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer